Imaging Endpoints is involved in extensive and cutting-edge COVID-19 imaging

Imaging Endpoints
News

We are offering the detection and standardized recording of the clinical and radiological disease features of COVID-19 infection, Radiomic Analysis, CD8+ Analysis and AI Analysis of SARS-CoV-2 for clinical trials. For more information, see https://imagingendpoints.com/covid-19/covid-analysis/

previous post: Big iData: Imaging Endpoints is uniquely positioned to house millions of images across multiple disease types in searchable databases that enable deep imaging research and development.
next post: Imaging Endpoints was founded to Connect Imaging to the Cure^™

Imaging Endpoints Congratulates Novartis on its FDA approval of Locametz® and Pluvicto™ for Selection and Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer

REAL-TIME READS